Tobacco Treatment Comparison for Cancer Care
A legfontosabb adatok
- Ki végzi
- University of Wisconsin, Madison
- Hol
- Madison (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Fázis
- 4. fázis
- Résztvevők
- 52 fő vett részt
- Kezdés
- 2024. márc. 1.
- Befejezés
- 2025. aug. 4.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Transdermal Nicotine Patch
- Standard Telephone Counseling
- Varenicline
- Cancer-Targeted Telephone Counseling
- Mailed Information about Standard Care Resources
- A regiszteradat frissítve
- 2025. október 27.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- Alive (per medical record)
- Diagnosed with cancer in the past 3 years
- Received care from a participating oncology clinic in the past year
- Has a current tobacco use status
- Does not have a preferred language other than English (missing language preference will be included)
- Valid address that is not a correctional facility or residential treatment/care facility
- No flag for patient cognitive impairment, activated health care power of attorney, or other health care agent (e.g., legally authorized representative) in the EHR; The following additional inclusion criteria must be met for inclusion in the CET
- Smoked combustible cigarettes in the past month
- Able to speak and understand English
- Willing to set a date to quit smoking in the next 60 days
- Willing to receive smoking treatment information
- Willing to complete study activities
Ki nem vehet részt
- Currently receiving treatment for bipolar disorder, schizophrenia, schizoaffective disorder, or psychotic disorder
- No current suicidal ideation
- Suicide attempt in the past year
- Incarceration
- Unable to provide informed consent to treatment (i.e., cannot answer questions about study procedures or risks after hearing about the study)
Helyszínek itt: Egyesült Államok
- UW Carbone Cancer CenterMadison, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This pilot comparative effectiveness trial will compare two active smoking cessation treatments in terms of effectiveness, equity across patient subpopulations, and efficiency among adult patients diagnosed with cancer within the past 3 years. An enhanced treatment comprising 12 weeks of varenicline treatment and 7 smoking cessation coaching calls with a cancer focus will be compared against an active comparator modeled after standard quitline treatments (2 weeks of nicotine patch therapy with 3 phone coaching calls). Approximately 50 participants will be recruited to generate estimates of the effects, acceptability, costs, and equity of enhanced treatment (vs. standard treatment), with the primary outcome being abstinence from smoking 26 weeks after trying to quit.
A vizsgálat 2 csoportja
- Low-Intensity Standard Smoking Cessation TreatmentMár használt kezelés, összehasonlításként
2 weeks of nicotine patch therapy, 3 telephone counseling sessions, and information about quitline and National Cancer Institute text messaging support services (SmokefreeTXT)
Kezelés: Transdermal Nicotine Patch, Standard Telephone Counseling és Mailed Information about Standard Care Resources
- High-Intensity, Cancer-Targeted Smoking Cessation TreatmentA vizsgált kezelés
12 weeks of varenicline therapy, 7 counseling sessions targeted to cancer patients, and information about quitline and SmokefreeTXT services
Kezelés: Varenicline, Cancer-Targeted Telephone Counseling és Mailed Information about Standard Care Resources
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Comparative Effectiveness Trial of Tobacco Cessation Treatments Among Cancer Patients Who Smoke
- A regiszteradat frissítve
- 2025. október 27.